Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$6,687,332
+$363,873 QoQ
Shares Held
26,575
-4.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#1,137
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Thomasville National Bank holds $88,456,516 across 10 Drug Manufacturers - General names. ABBV ranks #3 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
871,467 | $45,682,299 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
91,822 | $11,600,791 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
26,575 | $6,687,332 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,746 | $5,492,861 | |
| 5 | JNJ |
Johnson & Johnson
|
17,243 | $4,379,204 | |
| 6 | SNY |
Sanofi
|
99,727 | $4,254,353 | |
| 7 | LLY |
ELI LILLY & Co
|
3,349 | $4,016,891 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
51,534 | $2,969,388 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,687,332 | 26,575 | Shares | Other | 2026-07-20 | |
| 2025-12-31 | $6,323,459 | 27,675 | Shares | Other | 2026-01-26 | |
| 2025-09-30 | $6,357,625 | 27,458 | Shares | Other | 2025-10-10 | |
| 2025-06-30 | $5,107,890 | 27,518 | Shares | Other | 2025-07-11 | |
| 2025-03-31 | $6,302,361 | 30,080 | Shares | Other | 2025-04-16 | |
| 2024-12-31 | $5,315,362 | 29,912 | Shares | Other | 2025-01-13 | |
| 2024-09-30 | $5,952,441 | 30,142 | Shares | Other | 2024-10-11 | |
| 2024-06-30 | $5,303,055 | 30,918 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $5,658,392 | 31,073 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $4,846,686 | 31,275 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $4,790,042 | 32,135 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $4,307,856 | 31,974 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $5,121,673 | 32,137 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $5,273,657 | 32,632 | Shares | Other | 2023-01-10 | |
| 2022-09-30 | $4,400,074 | 32,785 | Shares | Sole | 2022-10-03 | |
| 2022-06-30 | $5,318,939 | 34,728 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $8,670,291 | 53,484 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $22,750,449 | 168,024 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $18,106,302 | 167,853 | Shares | Sole | 2021-10-04 | |
| 2021-06-30 | $18,779,340 | 166,720 | Shares | Sole | 2021-07-02 | |
| 2021-03-31 | $18,610,809 | 171,972 | Shares | Sole | 2021-04-01 | |
| 2020-12-31 | $17,258,542 | 161,069 | Shares | Sole | 2021-01-04 | |
| 2020-09-30 | $14,138,426 | 161,416 | Shares | Sole | 2020-10-01 | |
| 2020-06-30 | $16,578,576 | 168,859 | Shares | Sole | 2020-07-01 | |
| 2020-03-31 | $12,877,633 | 169,020 | Shares | Sole | 2020-04-02 | |
| No filing history on record for this holder in this stock. | ||||||